Pegylated Long-Acting Human Growth Hormone Is Well-Tolerated in Healthy Subjects and Possesses a Potential Once-Weekly Pharmacokinetic and Pharmacodynamic Treatment Profile
Rasmussen, Michael Højby, Bysted, Britta V., Anderson, Thomas W., Klitgaard, Thomas, Madsen, Jesper
Published in The journal of clinical endocrinology and metabolism (01.07.2010)
Published in The journal of clinical endocrinology and metabolism (01.07.2010)
Get full text
Journal Article
Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa
Karpf, Ditte M, Sørensen, Brit B, Hermit, Mette B, Holmberg, Heidi L, Tranholm, Mikael, Bysted, Britta V, Groth, Andreas V, Bjørn, Søren E, Stennicke, Henning R
Published in Thrombosis research (01.08.2011)
Published in Thrombosis research (01.08.2011)
Get full text
Journal Article
Pegylated Long-Acting Human Growth Hormone Is Well-Tolerated in Healthy Subjects and Possesses a Potential Once-Weekly Pharmacokinetic and Pharmacodynamic Treatment Profile
Rasmussen, Michael Højby, Bysted, Britta V, Anderson, Thomas W, Klitgaard, Thomas, Madsen, Jesper
Published in The journal of clinical endocrinology and metabolism (01.07.2010)
Published in The journal of clinical endocrinology and metabolism (01.07.2010)
Get full text
Journal Article